Related Experiment Video
Updated: Aug 15, 2026

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary
Dan-Mihai Dorobantu1,2, Qi Huang3, Ferran Espuny-Pujol3,4
1Children's Health and Exercise Research Centre (CHERC), Medical School, University of Exeter, United Kingdom (D.-M.D.).
Insights
Transcatheter right ventricular decompression is the preferred initial treatment for pulmonary atresia with intact ventricular septum, showing improved outcomes. Biventricular repair offers better long-term survival but requires more reinterventions than single-ventricle palliation.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Disease
- Surgical Outcomes
Background:
- Pulmonary atresia with intact ventricular septum (PA/IVS) management has evolved.
- Increased use of transcatheter right ventricular decompression (RVAD) is noted.
- Contemporary outcomes following RVAD in PA/IVS patients are largely unknown.
Purpose of the Study:
- To evaluate contemporary national outcomes in PA/IVS patients aged 0-18 years.
- To assess the impact of different treatment pathways on mortality, reintervention, and hospital stay.
Main Methods:
- Retrospective analysis of PA/IVS patients (2000-2022) in England and Wales.
- Linking national data sets for comprehensive outcome assessment.
- Stratification by initial intervention: RVAD, stage 1 palliation, or pre-intervention death/loss.
Main Results:
- 58.8% underwent RVAD (84.8% transcatheter); 32.4% received stage 1 palliation.
- 54.5% achieved biventricular (BiV) repair; 26.7% underwent single-ventricle palliation.
- 1-year mortality: 7.7% for RVAD vs. 37.2% for stage 1 palliation. 10-year reintervention: 62.6% post-BiV repair vs. 32.8% post-stage 3 palliation.
Conclusions:
- Transcatheter RVAD is the predominant initial intervention for PA/IVS, with lower in-hospital mortality than historical series.
- BiV repair is achievable in over half of patients, offering better long-term survival but higher reintervention rates.
- Early mortality remains high in severe cases; single-ventricle palliation has lower reintervention but more hospital days.
Background:
Pulmonary atresia with intact ventricular septum management has evolved, with increased use of transcatheter right ventricular decompression, but the impact on contemporary outcomes remains unknown. This study evaluates contemporary national outcomes in patients aged 0 to 18 years.
Methods:
Patients with pulmonary atresia with intact ventricular septum undergoing cardiac intervention (2000-2022) in England and Wales were linked to multiple national data sets. Mortality (early and late), reintervention, and hospital stay were described overall and by treatment pathway.
Results:
Among 488 included patients with pulmonary atresia with intact ventricular septum, 58.8% underwent right ventricular decompression as the first procedure, predominantly transcatheter (84.8%), while 32.4% received stage 1 palliation (arteriopulmonary shunt or ductal stenting), and 8.8% died or were lost to follow-up before either intervention. Overall, 54.5% achieved biventricular (BiV) repair, 26.7% underwent functionally single-ventricle palliation, and 18.8% were noncommitted. Overall group in-hospital mortality was 11.7%. The median follow-up was 8.9 years, with 1- and 5-year mortality of 19.8% (95% CI, 16.2%-23.2%) and 20.8% (95% CI, 17.1%-24.4%), respectively. Stage 1 palliation as the initial therapy had higher 1-year mortality than right ventricular decompression (37.2% [29.0%-44.5%] versus 7.7% [4.5%-10.7%]). Cardiac reintervention was 62.6% (56.1%-68.4%) at 10 years after BiV repair and 32.8% (21.5%-44.4%) at 10 years after palliative stage 3. Median hospital stay was greatest in the first year (35 days), declining to 2 days annually by 10 years, with functionally single-ventricle patients requiring more days in hospital than BiV patients (52 versus 28).
Conclusions:
In a contemporary pulmonary atresia with intact ventricular septum cohort, transcatheter right ventricular decompression was the predominant initial intervention. This approach had lower in-hospital mortality compared with older multicenter series, with BiV repair achieved in more than half of the patients. Early mortality after nonantegrade flow augmentation remains high, likely due to nonmodifiable risk factors in severe cases. Long-term survival and hospital stay remain better for those amenable to BiV circulation, reflecting more favorable anatomy compared with those on the single-ventricle pathway, although reintervention is lower in the latter.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pulmonary Cycle: Exhalation
Pneumothorax II: Pathophysiology
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Atelectasis II: Pathophysiology
